Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: A pilot trial in the prevention of contrast nephropathy
- 1 May 2002
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 143 (5) , 894-903
- https://doi.org/10.1067/mhj.2002.122118
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptorsKidney International, 1999
- Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medullaKidney International, 1998
- Contrast-medium-induced acute renal failureKidney International, 1998
- Renal microcirculation and tissue damage during acute ureteral obstruction in the rat: Effect of saline infusion, indomethacin and radiocontrastKidney International, 1997
- Differential Human Renal Tubular Responses to Dopamine Type 1 Receptor Stimulation Are Determined by Blood Pressure StatusHypertension, 1997
- Radiocontrast–induced nephropathy in humans: Role of renal vasoconstrictionKidney International, 1992
- Cardiovascular Function During Induced Hypotension by Fenoldopam or Sodium Nitroprusside in Anesthetized DogsAnesthesia & Analgesia, 1992
- Early renal medullary hypoxic injury from radiocontrast and indomethacinKidney International, 1991
- Hospital-acquired renal insufficiency: A prospective studyThe American Journal of Medicine, 1983
- Effects of dopamine on canine intrarenal blood flow distribution during hemorrhageKidney International, 1979